A detailed history of Commerce Bank transactions in Organon & Co. stock. As of the latest transaction made, Commerce Bank holds 12,168 shares of OGN stock, worth $188,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,168
Previous 11,531 5.52%
Holding current value
$188,360
Previous $238,000 2.52%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$18.65 - $23.03 $11,880 - $14,670
637 Added 5.52%
12,168 $232,000
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $28,583 - $35,970
-1,638 Reduced 12.44%
11,531 $238,000
Q1 2024

May 03, 2024

SELL
$13.78 - $18.8 $9,094 - $12,408
-660 Reduced 4.77%
13,169 $247,000
Q4 2023

Feb 09, 2024

SELL
$10.95 - $17.32 $3,821 - $6,044
-349 Reduced 2.46%
13,829 $199,000
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $21,517 - $30,829
-1,297 Reduced 8.38%
14,178 $246,000
Q2 2023

Aug 08, 2023

SELL
$19.27 - $24.63 $249,835 - $319,327
-12,965 Reduced 45.59%
15,475 $322,000
Q1 2023

May 04, 2023

SELL
$21.42 - $32.08 $1,370 - $2,053
-64 Reduced 0.22%
28,440 $668,000
Q4 2022

Feb 10, 2023

SELL
$23.31 - $28.61 $58,927 - $72,326
-2,528 Reduced 8.15%
28,504 $796,000
Q3 2022

Nov 04, 2022

BUY
$23.4 - $34.25 $12,425 - $18,186
531 Added 1.74%
31,032 $726,000
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $44,355 - $54,498
-1,401 Reduced 4.39%
30,501 $1.03 Million
Q1 2022

May 09, 2022

SELL
$30.45 - $39.36 $165,982 - $214,551
-5,451 Reduced 14.59%
31,902 $1.11 Million
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $216,114 - $279,885
-7,538 Reduced 16.79%
37,353 $1.14 Million
Q3 2021

Nov 09, 2021

SELL
$28.63 - $35.64 $932,450 - $1.16 Million
-32,569 Reduced 42.05%
44,891 $1.47 Million
Q2 2021

Aug 09, 2021

BUY
$28.45 - $38.0 $2.2 Million - $2.94 Million
77,460 New
77,460 $2.34 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.94B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.